Literature DB >> 21904494

Current surveillance and therapeutic options for barrett esophagus.

Corley Douglas1.   

Abstract

Year:  2008        PMID： 21904494      PMCID： PMC3088295     

Source DB:  PubMed          Journal:  Gastroenterol Hepatol (N Y)        ISSN： 1554-7914


× No keyword cloud information.
  7 in total

1.  Early experience with radiofrequency energy ablation therapy for Barrett's esophagus with and without dysplasia.

Authors:  A K Roorda; S N Marcus; G Triadafilopoulos
Journal:  Dis Esophagus       Date:  2007       Impact factor: 3.429

2.  Chromoendoscopy and narrow-band imaging compared with high-resolution magnification endoscopy in Barrett's esophagus.

Authors:  Wouter Curvers; Lubbertus Baak; Ralf Kiesslich; Arnoud Van Oijen; Thomas Rabenstein; Krish Ragunath; Jean-Francois Rey; Pieter Scholten; Uwe Seitz; Fiebo Ten Kate; Paul Fockens; Jacques Bergman
Journal:  Gastroenterology       Date:  2008-01-10       Impact factor: 22.682

3.  Endoscopic therapy for high-grade dysplasia in Barrett's esophagus: ablate, resect, or both?

Authors:  Prateek Sharma; Sachin Wani; Amit Rastogi
Journal:  Gastrointest Endosc       Date:  2007-09       Impact factor: 9.427

4.  Long-term outcome of medical and surgical therapies for gastroesophageal reflux disease: follow-up of a randomized controlled trial.

Authors:  S J Spechler; E Lee; D Ahnen; R K Goyal; I Hirano; F Ramirez; J P Raufman; R Sampliner; T Schnell; S Sontag; Z R Vlahcevic; R Young; W Williford
Journal:  JAMA       Date:  2001-05-09       Impact factor: 56.272

5.  Surveillance and survival in Barrett's adenocarcinomas: a population-based study.

Authors:  Douglas A Corley; Theodore R Levin; Laurel A Habel; Noel S Weiss; Patricia A Buffler
Journal:  Gastroenterology       Date:  2002-03       Impact factor: 22.682

6.  Impact of colorectal cancer screening on future lifestyle choices: a three-year randomized controlled trial.

Authors:  Inger K Larsen; Tom Grotmol; Kari Almendingen; Geir Hoff
Journal:  Clin Gastroenterol Hepatol       Date:  2007-03-23       Impact factor: 11.382

7.  Five-year efficacy and safety of photodynamic therapy with Photofrin in Barrett's high-grade dysplasia.

Authors:  Bergein F Overholt; Kenneth K Wang; J Steven Burdick; Charles J Lightdale; Michael Kimmey; Hector R Nava; Michael V Sivak; Norman Nishioka; Hugh Barr; Norman Marcon; Marcos Pedrosa; Mary P Bronner; Michael Grace; Michelle Depot
Journal:  Gastrointest Endosc       Date:  2007-07-23       Impact factor: 9.427
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.